The Thalassaemia International Federation Hosts the 2nd Cyprus National Mirror Group Meeting
Thalassaemia International Federation (TIF) posted on LinkedIn:
”2nd Annual Cyprus National Mirror Group (CYNMG) Meeting
The Thalassaemia International Federation (TIF) was pleased to host the 2nd Cyprus National Mirror Group (CYNMG) Meeting, held under the framework of the European Rare Disease Research Alliance (ERDERA).
What is ERDERA?
ERDERA is a European initiative that strengthens research and collaboration on rare diseases by uniting national efforts and ensuring that patient and stakeholder voices are represented at both national and European levels.
What are National Mirror Groups (NMGs)?
NMGs are the national arms of ERDERA, bringing together key actors in each country, from researchers and clinicians to patient organisations and policymakers, to align priorities and contribute to the European rare disease agenda.
This year’s meeting was highly constructive, with stakeholders across Cyprus’ rare disease community recognizing the importance of holding regular meetings to:
– exchange knowledge,
– identify shared challenges and priorities, and
– explore opportunities for collaboration.
Thanks to The Cyprus National Rare Diseases Committee, Monadika Xamogela, The Clinical Genetics and Metabolic Disorders Clinic of the Makarios III Hospital, Karaiskakio Foundation, Cyprus Federation of Patients’ Associations (CyFPA), Cyprus Alliance for Rare Disorders (CARD), and The Cyprus Institute of Neurology and Genetics (CING) for joining and contributing to this important discussion.”
Stay updated with Hemostasis Today.
-
Sep 29, 2025, 12:54Microfluidic Technology Uncovers Ongoing TTP Disease Activity
-
Sep 29, 2025, 12:43Advancing Thrombosis Research: MRI-Based Methodology for Studying Thrombus Resolution
-
Sep 29, 2025, 05:58Samwel Mikaye on Understanding, Diagnosing, and Managing Deep Venous Thrombosis (DVT)
-
Sep 28, 2025, 14:08Mary Cushman: Dr Warkentin Is a Giant in Hematology
-
Sep 28, 2025, 13:31Michael Makris Highlights Vaccine Misinformation and Its Risks
-
Sep 29, 2025, 12:33Allison Wheeler: Some Days I Love Science a Little Bit More
-
Sep 29, 2025, 06:23Yudi Hardianto and Colleagues Give a Review on Stroke Rehabilitation in LMICs
-
Sep 29, 2025, 04:42Wolfgang Miesbach on the Bi8 Study: A Novel FVIII-Mimetic Antibody Gene Therapy for Haemophilia A
-
Sep 29, 2025, 04:16Salvador Payán Pernía on Equity Challenges in Access to Gene Therapy for Hemoglobinopathies
-
Sep 29, 2025, 04:02Nicolas Gendron: A Very Nice Demonstration by The Authors - Coffee is Associated with Reduced Risk of VTE
-
Sep 29, 2025, 05:06Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
-
Sep 24, 2025, 11:06Wolfgang Miesbach Reports Promising Results for New Subcutaneous von Willebrand Disease Therapy VGA039
-
Sep 23, 2025, 06:40Richard Buka: CSL Behring Have Announced a Collaboration with Dutch Biotech, VarmX
-
Sep 22, 2025, 07:10Aspirin Beyond the Heart․ Targeting PI3K-Altered Colorectal Cancer
-
Sep 22, 2025, 06:04ClearPlasma: A New Filter Technology to Enhance Clot Stability in Donated Plasma
-
Sep 29, 2025, 07:02Kambua Manundu: We Walked to Protest the Countless Lives of Women We Have Lost to Post Partum Hemorrhage
-
Sep 29, 2025, 06:41Ouma Oluga Unveiled Plans to Make Sickle Cell Screening Mandatory in Kenya at 80th UN General Assembly
-
Sep 29, 2025, 04:51Nathan Connell on Breakthrough Gene Therapy Advancing Care for People with Hemophilia
-
Sep 29, 2025, 04:28Emmeran Hauser: Fantastic to See First Results of Our Work in Europe
-
Sep 28, 2025, 10:33Côme Bommier: Burnout Is Common Among Hematology Professionals